Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
Abbott, abridged, Acceleron, accidental, adjacent, ancillary, appeal, argued, arriving, ASLAN, begun, behavior, BeiGene, bidding, billion, bio, bluebird, blueprint, BMS, boost, Brequinar, Cadillac, CAT, chaired, channel, checkpoint, chose, Circuit, compassionate, composed, concession, condensed, constraint, contrary, corridor, credibility, creditworthy, Creek, CStone, customary, dashboard, Daurismo, deeply, depth, dialogue, District, donut, droit, elderly, embryonic, endorsement, exact, Excellence, excise, expedient, experimental, explicit, expressly, falsification, familiar, feature, gag, gaming, GDPR, HHS, hole, Hong, Iceland, impaneled, Importantly, inactivation, indefinitely, input, insert, inseverable, judge, Keytruda, Kong, laid, leakage, Liechtenstein, line, locked, lodge, lot, Macau, mainland, membership, misuse, mitapivat, modest, molecularly, monotherapy, month, multidisciplinary, Mylotarg, Northern, OCE, Opdivo, PA, Paediatric, Parliament, PDCO, penalty, perception, pertinent, pharmacy, pilot, pocket, practitioner, pre, predominant, presidential, PRIME, proactive, radiopharmaceutical, rapporteur, reassessment, referenda, relaxing, reprioritize, resell, restraining, RTOR, Rydapt, sNDA, SNO, sophisticated, speed, SSP, ST, straight, subcontractor, supervisory, supplementary, Supreme, Taiwan, Territory, TIBSOVO, TriCare, turnover, uncollectible, unfairly, unsatisfied, unsecured, upheld, vehicle, Venclexta, virtually, vorasidenib, Xospata, Yervoy
Removed:
Alexion, allocable, allogeneic, arising, aromatase, arrange, attach, bacterial, Calithera, carryback, certainty, concurrently, Conference, continuously, correction, CR, CRi, CRp, CRs, cytarabine, daunorubicin, deliverable, deterioration, diarrhea, discontinued, discounted, discretionary, doubtful, effusion, eleven, entail, equally, etoposide, eventually, expression, extending, febrile, fighting, finalize, footnote, founded, Genzyme, headcount, idarubicin, IEC, immature, incomplete, intrahepatic, IPAB, IPO, median, misleading, mission, mitoxantrone, moderate, MTD, mutating, neutropenia, owner, path, payroll, pervasive, platelet, PR, pretreatment, progressed, prolongation, QSR, QT, rationale, Raze, refundable, reinduction, relapse, remained, remit, retrospectively, Room, sampling, Sanofi, scale, Selvita, shelf, shipping, Shire, shut, SmPC, stable, steering, sublicense, tested, transferred, transplantation, unfair, unlock, unscheduled, untreated, vested, voucher, Washington, white, worthy
Filing tables
Filing exhibits
Related press release
Associated AGIO transcripts
AGIO similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-223031, 333-216106, 333-209755, 333-201796, 333- 193802, and 333-190101) and Form S-3 (No. 333-221960) of Agios Pharmaceuticals, Inc. of our report dated February 14, 2019 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
February 14, 2019